Acasti Financial Statements From 2010 to 2024
| ACSTDelisted Stock | USD 3.37 0.01 0.30% |
Check Acasti Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Acasti Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Acasti financial statements analysis is a perfect complement when working with Acasti Pharma Valuation or Volatility modules.
Acasti |
Acasti Pharma Company Shares Owned By Insiders Analysis
Acasti Pharma's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Acasti Pharma Shares Owned By Insiders | 38.39 % |
Most of Acasti Pharma's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Acasti Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 38.39% of Acasti Pharma are shares owned by insiders. This is 152.9% higher than that of the Pharmaceuticals sector and 170.73% higher than that of the Health Care industry. The shares owned by insiders for all United States stocks is notably lower than that of the firm.
Acasti Pharma Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Acasti Pharma's current stock value. Our valuation model uses many indicators to compare Acasti Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Acasti Pharma competition to find correlations between indicators driving Acasti Pharma's intrinsic value. More Info.Acasti Pharma is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Acasti Pharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Acasti Pharma Financial Statements
Acasti Pharma shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Acasti Pharma investors may analyze each financial statement separately, they are all interrelated. The changes in Acasti Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on Acasti Pharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. The company was incorporated in 2002 and is headquartered in Laval, Canada. Acasti Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Acasti Stock
If you are still planning to invest in Acasti Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acasti Pharma's history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |